Jul 16, 2026 06:47AM
Jul 15, 2026 07:00AM
Jul 15, 2026 07:00AM
Jul 14, 2026 07:00AM
Jul 7, 2026 07:00AM
Jul 7, 2026 07:00AM
Jun 26, 2026 07:00AM Axsome starts Phase 3 trial of solriamfetol for adolescent ADHD
Jun 26, 2026 07:00AM
Jun 18, 2026 07:00AM
Jun 18, 2026 07:00AM
Jun 15, 2026 07:02AM
Jun 15, 2026 07:00AM
Jun 4, 2026 07:00AM
Jun 4, 2026 06:40AM H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM)
Jun 3, 2026 07:04AM
Jun 3, 2026 07:00AM
Jun 1, 2026 07:03AM
Jun 1, 2026 07:00AM
May 27, 2026 07:00AM
May 26, 2026 07:00AM
May 7, 2026 07:00AM Axsome Therapeutics Recognizes Mental Health Month
May 5, 2026 07:00AM
May 4, 2026 01:15PM
May 4, 2026 07:33AM
May 4, 2026 07:00AM
May 1, 2026 07:15AM
May 1, 2026 07:15AM
Apr 30, 2026 05:15PM Axsome Therapeutics (AXSM) PT Raised to $250 at Oppenheimer
Apr 30, 2026 02:06PM
Apr 30, 2026 02:06PM
Apr 10, 2026 09:31AM
Apr 8, 2026 07:00AM
Apr 1, 2026 05:41PM
Apr 1, 2026 07:00AM
Apr 1, 2026 07:00AM Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions
Mar 25, 2026 06:07AM
Feb 25, 2026 07:00AM
Feb 24, 2026 07:00AM
Feb 24, 2026 07:00AM
Feb 23, 2026 12:17PM
Feb 23, 2026 07:00AM
Feb 18, 2026 07:00AM Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb 17, 2026 07:00AM
Jan 27, 2026 07:00AM
Jan 15, 2026 07:00AM
Jan 15, 2026 07:00AM
Jan 12, 2026 07:08AM
Jan 12, 2026 07:00AM
Jan 8, 2026 03:37AM Morgan Stanley Downgrades Axsome Therapeutics (AXSM) to Equalweight
Jan 5, 2026 06:40AM

326,104 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All